Cardinal Health extends CVS Health pharmaceutical distribution agreement through June 2032
CAH•Cardinal Health signed a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032, keeping current distribution services in place. It reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%, or $12.40 to $12.60, and its long-term growth target of 12% to 14%.
1. Distribution agreement extended
Cardinal Health signed a binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The renewal keeps the current scope of distribution services in place.
2. Guidance reaffirmed
Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%, implying $12.40 to $12.60. Its long-term non-GAAP EPS growth target remains 12% to 14%.
